BACKGROUND: Neonatal sepsis is a major cause of death and complications despite antibiotic treatment. Effective adjunctive treatments are needed. Newborn infants are relatively deficient in endogenous immunoglobulin. Meta-analyses of trials of intravenous immune globulin for suspected or proven neonatal sepsis suggest a reduced rate of death from any cause, but the trials have been small and have varied in quality. METHODS: At 113 hospitals in nine countries, we enrolled 3493 infants receivin...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Treatment of neonatal sepsis with intravenous immune globulin.
If you are the owner of this record, you can report an update to it here: Report update to this record